Delivery Order 75N94020D00013-75N94023F00001

Award Date 9/28/23
Potential Completion Date 3/28/25
Potential Value $87K
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
New York, NY 10032, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
16
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the finalization of the protocol, regulatory approval, start-up, and commencement of recruitment, screening, and enrollment for the Ovaprene vaginal device clinical trial. The contract, valued at $251,482.00, was awarded by the National Institute of Child Health and Human Development (NICHD) to Oregon Health & Science University (OHSU), a state-controlled institution of higher learning. The contract is a Delivery Order with a Cost No Fee pricing type, and...
The National Institute of Child Health and Human Development (NICHD), a civilian federal agency, has awarded a $43,865.00 delivery order contract to The Regents of the University of California, San Francisco (UCSF) for the "OVAPRENE PHASE 1: PROTOCOL FINALIZATION, REGULATORY APPROVAL, START-UP, AND COMMENCEMENT OF RECRUITMENT, SCREENING, AND ENROLLMENT FOR THE OVAPRENE VAGINAL DEVICE CLINICAL TRIAL." This contract, which does not have a set-aside designation, supports activities...
This is a federal contract award from the National Institute of Child Health and Human Development (NICHD) to the Magee-Womens Research Institute And Foundation, a non-profit research organization focused on women's health. The $183,306 contract is for a Phase 1 clinical trial of the Ovaprene vaginal contraceptive device. This award is a delivery order under the $5 million IDIQ contract the institute holds with NICHD to participate in the Contraceptive Clinical Trials Network. The contract has...
This is a $349,327 delivery order awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency, to Essential Access Health, a non-profit organization. The delivery order is for finalizing the protocol, obtaining regulatory approval, and commencing recruitment and enrollment for a clinical trial of the Ovaprene vaginal device. This award is part of a larger $5 million indefinite delivery contract with NICHD to conduct clinical trials and develop protocols...
The National Institute of Child Health and Human Development (NICHD), a component of the U.S. Department of Health and Human Services, awarded a $610,510.67 cost-reimbursement delivery order contract to The Trustees of Columbia University in the City of New York (Columbia University) to conduct a contraceptive clinical trial network and evaluate novel products for female contraception, including pilot and efficacy studies. This contract, which does not have a set-aside designation, has an...
This is a federal contract award to The Trustees of Columbia University in the City of New York, operating as the Health Sciences Division, by the National Institute of Child Health and Human Development (NICHD), a component of the U.S. Department of Health and Human Services. The contract is for a randomized controlled clinical trial to study the efficacy, safety, and acceptability of a female contraceptive product called C31G. The contract has a ceiling value of $902,337.00 and was awarded...
This is a delivery order contract awarded to The Trustees of Columbia University in the City of New York (Columbia University) by the National Institute of Child Health and Human Development (NICHD), a component of the Department of Health and Human Services. The contract is for a multi-center, randomized study to evaluate the pharmacokinetic and pharmacodynamic profile, contraceptive efficacy, and safety of daily oral low-dose ulipristal acetate. This is not a set-aside contract. The contract...
This federal contract award is for "CORE FUNCTION ACTIVITIES TO PROVIDE ASSISTANCE IN PROTOCOL REVIEW, PROTOCOL DEVELOPMENT AND ACTIVITIES ASSOCIATED WITH PAST, PRESENT, AND FUTURE OF THE CONTRACEPTIVE CLINICAL TRIALS NETWORK (FEMALE SITES) ACTIVITIES." The contract, valued at $142,586.94, was awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services. The prime contractor is The Trustees of...
This federal contract award, with an ID of 75N94020D00013|75N94020F00001, was issued by the National Institute of Child Health and Human Development (NICHD) to The Trustees of Columbia University in the City of New York, doing business as the Health Sciences Division. The contract, which is not set-aside, is for $97,659.00 and is to assist in the development of new contraceptive products by providing services related to protocol review, protocol development, and activities associated with the...
This federal contract award, with an ID of 75N94019D00004|75N94023F00003, was issued by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the Department of Health and Human Services. The $2,160,831.00 delivery order was awarded to Health Decisions, Inc., a for-profit organization, to provide services including finalization, procurement of regulatory approval, and complete start-up activities for the Ovaprene vaginal device clinical trial. This order...
  • 75N94020D00013
    Indefinite Delivery Contract
  • 75N94020D00013-75N94023F00001
    Delivery Order

This federal contract award to The Trustees of Columbia University in the City of New York, doing business as the Health Sciences Division, is for the OVAPRENE PHASE 1 - PROTOCOL FINALIZATION, PROCUREMENT OF REGULATORY APPROVAL, AND COMPLETE START-UP ACTIVITIES FOR THE OVAPRENE VAGINAL DEVICE CLINICAL TRIAL. The contract has a ceiling value of $87,270.00 and a period of performance through March 28, 2025. It was awarded by the National Institute of Child Health and Human Development, a civilian agency, under a delivery order contract type without a set-aside designation. The award represents work under the OVAPRENE major program, which is focused on the development of a novel contraceptive device. Columbia University is the prime contractor for this contract, leveraging its extensive expertise in biomedical research, clinical services, and government contracting to support this critical women's health initiative.

Generated 4/25/25, 10:04 AM